Neutropenia  >>  Rolvedon (eflapegrastim-xnst)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rolvedon (eflapegrastim-xnst) / Assertio
NEUTHREE, NCT05949333: Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy

Recruiting
4
100
RoW
Eflapegrastim, Rolvedon, Eflapegrastim-xnst, HM-10460A, SPI-2012
Eunseong Medical Foundation Good GANG-AN HOSPITAL, Hanmi Pharmaceutical Company Limited
Breast Neoplasms
01/25
07/25

Download Options